Fig. 4
From: Elevated TNFRSF4 gene expression is a predictor of poor prognosis in non-M3 acute myeloid leukemia
Survival analysis of patients with respect to TNFRSF4 expression after stratification based on TP53, NPM1, FLT3 and RUNX1 mutation status. Overall survival of patients with TNFRSF4 high (Z score ≥ 0) versus TNFRSF4 low (Z score < 0) among patients with aTP53, bNPM1, cFLT3 and dRUNX1 wild-type gene. e Overall survival of patients with TNFRSF4 high (Z score ≥ 0) versus TNFRSF4 low (Z score < 0) among patients with RUNX1 mutated gene